Mirae Asset Global Investments Co., Ltd. Harmony Biosciences Holdings, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$28 Billion
Q2 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,218 shares of HRMY stock, worth $63,368. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,218

Previous 1,919 15.58%

Holding current value

$63,368

Previous $63,000 11.11%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	BUY	$27.94 - $35.91 $8,354 - $10,737	299 Added 15.58%	2,218 $70,000
Q1 2025 Apr 24, 2025	BUY	$32.18 - $40.46 $611 - $768	19 Added 1.0%	1,919 $63,000
Q4 2024 Jan 27, 2025	SELL	$31.86 - $41.49 $4,970 - $6,472	-156 Reduced 7.59%	1,900 $65,000
Q3 2024 Oct 23, 2024	BUY	$30.0 - $39.95 $10,800 - $14,382	360 Added 21.23%	2,056 $82,000
Q2 2024 Jul 30, 2024	SELL	$28.81 - $33.01 $324,285 - $371,560	-11,256 Reduced 86.91%	1,696 $51,000
Q1 2024 May 01, 2024	SELL	$29.93 - $35.06 $108,047 - $126,566	-3,610 Reduced 21.8%	12,952 $434,000
Q4 2023 Jan 24, 2024	BUY	$19.2 - $33.78 $998 - $1,756	52 Added 0.31%	16,562 $534,000
Q3 2023 Oct 26, 2023	BUY	$31.89 - $39.03 $1,753 - $2,146	55 Added 0.33%	16,510 $541,000
Q2 2023 Aug 10, 2023	BUY	$30.5 - $37.4 $113,368 - $139,015	3,717 Added 29.18%	16,455 $579,000
Q1 2023 May 04, 2023	SELL	$30.8 - $53.92 $924 - $1,617	-30 Reduced 0.23%	12,738 $415,000
Q4 2022 Feb 09, 2023	BUY	$45.4 - $60.91 $12,621 - $16,932	278 Added 2.23%	12,768 $703,000
Q3 2022 Nov 10, 2022	BUY	$42.06 - $55.45 $525,329 - $692,570	12,490 New	12,490 $553,000

Others Institutions Holding HRMY

# of Institutions

291

Shares Held

46.3M

Call Options Held

316K

Put Options Held

69.9K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.69B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Harmony Biosciences Holdings, Inc. Transaction History